BIOMAT Database Logo BIOMAT Database Logo

[Experience with the Tavegil therapy of chronic pruritic dermatoses]. 1972

B A Somov, and Iu S Butov, and I N Vinokurov, and Iu Z Berezhnoi, and V I Kulagin

UI MeSH Term Description Entries
D009450 Neurodermatitis An extremely variable eczematous skin disease that is presumed to be a response to prolonged vigorous scratching, rubbing, or pinching to relieve intense pruritus. It varies in intensity, severity, course, and morphologic expression in different individuals. Neurodermatitis is believed by some to be psychogenic. The circumscribed or localized form is often referred to as lichen simplex chronicus. Lichen Simplex Chronicus,Neurodermatitis, Circumscribed,Neurodermatitis, Localized,Circumscribed Neurodermatitides,Circumscribed Neurodermatitis,Localized Neurodermatitides,Localized Neurodermatitis,Neurodermatitides,Neurodermatitides, Circumscribed,Neurodermatitides, Localized
D011537 Pruritus An intense itching sensation that produces the urge to rub or scratch the skin to obtain relief. Itching,Pruritis
D011565 Psoriasis A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D011759 Pyrrolidines Compounds also known as tetrahydropyridines with general molecular formula (CH2)4NH. Tetrahydropyridine,Tetrahydropyridines
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D002974 Clemastine A histamine H1 antagonist used as the hydrogen fumarate in hay fever, rhinitis, allergic skin conditions, and pruritus. It causes drowsiness. Meclastine,Mecloprodin,2-(2-(1-(4-Chlorophenyl)-1-phenylethoxy)ethyl)-1-methylpyrrolidine,Clemastine Fumarate,HS-592,Tavegyl,Tavist,HS 592,HS592
D003879 Dermatologic Agents Drugs used to treat or prevent skin disorders or for the routine care of skin. Agent, Dermatologic,Agent, Dermatological,Agents, Dermatologic,Dermatologic Agent,Dermatological Agents,Agents, Dermatological,Dermatological Agent
D004485 Eczema A dermatitis characterized by a spongiotic tissue reaction pattern occurring as a reaction to many endogenous and exogenous agents. Dermatitis, Eczematous,Eczematous Dermatitis
D006634 Histamine H1 Antagonists Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. Antihistamines, Classical,Antihistaminics, Classical,Antihistaminics, H1,Histamine H1 Antagonist,Histamine H1 Receptor Antagonist,Histamine H1 Receptor Antagonists,Histamine H1 Receptor Blockaders,Antagonists, Histamine H1,Antagonists, Histamine H1 Receptor,Antihistamines, Sedating,Blockaders, Histamine H1 Receptor,First Generation H1 Antagonists,H1 Receptor Blockaders,Histamine H1 Blockers,Receptor Blockaders, H1,Antagonist, Histamine H1,Classical Antihistamines,Classical Antihistaminics,H1 Antagonist, Histamine,H1 Antagonists, Histamine,H1 Antihistaminics,Sedating Antihistamines
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

B A Somov, and Iu S Butov, and I N Vinokurov, and Iu Z Berezhnoi, and V I Kulagin
[Therapy of pruritic dermatoses].
February 1953, Medizinische Klinik,
B A Somov, and Iu S Butov, and I N Vinokurov, and Iu Z Berezhnoi, and V I Kulagin
Pruritic dermatoses. Oral treatment of pruritic dermatoses with dexamethasone.
December 1959, Medical times,
B A Somov, and Iu S Butov, and I N Vinokurov, and Iu Z Berezhnoi, and V I Kulagin
[PUVA therapy of pruritic dermatoses].
August 1979, Sovetskaia meditsina,
B A Somov, and Iu S Butov, and I N Vinokurov, and Iu Z Berezhnoi, and V I Kulagin
[On the treatment of dermatoses with the antihistaminic Tavegil].
February 1968, Die Medizinische Welt,
B A Somov, and Iu S Butov, and I N Vinokurov, and Iu Z Berezhnoi, and V I Kulagin
[Experiences with Tavegil in dermatoses associated with pruritus].
December 1972, Die Medizinische Welt,
B A Somov, and Iu S Butov, and I N Vinokurov, and Iu Z Berezhnoi, and V I Kulagin
The pruritic dermatoses.
January 1981, Comprehensive therapy,
B A Somov, and Iu S Butov, and I N Vinokurov, and Iu Z Berezhnoi, and V I Kulagin
Pruritic dermatoses: overview of etiology and therapy.
December 2002, The American journal of medicine,
B A Somov, and Iu S Butov, and I N Vinokurov, and Iu Z Berezhnoi, and V I Kulagin
[Result of ambulatory dimedrol therapy of patients with pruritic dermatoses].
June 1961, Vestnik rentgenologii i radiologii,
B A Somov, and Iu S Butov, and I N Vinokurov, and Iu Z Berezhnoi, and V I Kulagin
[Experience with hemodialysis in the therapy of various chronic dermatoses].
June 1967, Sovetskaia meditsina,
B A Somov, and Iu S Butov, and I N Vinokurov, and Iu Z Berezhnoi, and V I Kulagin
[The antihistaminic preparation Tavegil in the treatment of certain dermatoses].
November 1969, Vestnik dermatologii i venerologii,
Copied contents to your clipboard!